Hair nicotine concentration of cats with gastrointestinal lymphoma and unaffected control cases

Evaluation of canine and feline tumors in Morocco: Results of a prospective observational study of 250 cases (2020-2023)

This work aimed to evaluate the histologic tumor types and patient characteristics of canine and feline neoplasias in Morocco. In a prospective, observational study, 250 tumor samples were collected from veterinary clinics in Morocco. For each case, breed, age, sex, neuter status, and tumor site and histotype were analyzed. Among the 250 tumors, 201 (80.4%) were from dogs and 49 (19.6%) from cats. Most common tumor location in dogs was the reproductive tract (36.8%), followed by skin and soft tissues (27.4%) and mammary gland (14.9%). In cats, most tumors originated from the skin and soft tissues (55.1%), followed by mammary gland (20.4%) and oral cavity (14.3%). Commonest canine histologic tumor types were transmissible venereal tumor (CTVT1) (31.8%) and mammary carcinoma (14.4%). Squamous cell carcinoma (34.7%) and mammary carcinoma (20.4%) represented the most frequent feline neoplasms. Median age of dogs and cats at diagnosis was 7 and 10 years, respectively. Gender distribution was even in dogs; in cats, females were overrepresented. Most cats and about half of dogs were mixed-breed. The evaluated canine and feline neoplasias show differences in their tumor types and patient characteristics when compared to populations from other countries, in part based on the high number of CTVT and - possibly solar-induced -feline skin tumors.

ACVIM consensus statement guidelines on diagnosing and distinguishing low-grade neoplastic from inflammatory lymphocytic chronic enteropathies in cats

BACKGROUND

Lymphoplasmacytic enteritis (LPE) and low-grade intestinal T cell lymphoma (LGITL) are common diseases in older cats, but their diagnosis and differentiation remain challenging.

OBJECTIVES

To summarize the current literature on etiopathogenesis and diagnosis of LPE and LGITL in cats and provide guidance on the differentiation between LPE and LGITL in cats. To provide statements established using evidence-based approaches or where such evidence is lacking, statements based on consensus of experts in the field.

ANIMALS

None.

METHODS

A panel of 6 experts in the field (2 internists, 1 radiologist, 1 anatomic pathologist, 1 clonality expert, 1 oncologist) with the support of a human medical immunologist, was formed to assess and summarize evidence in the peer-reviewed literature and complement it with consensus recommendations.

RESULTS

Despite increasing interest on the topic for clinicians and pathologists, few prospective studies were available, and interpretation of the pertinent literature often was challenging because of the heterogeneity of the cases. Most recommendations by the panel were supported by a moderate or low level of evidence. Several understudied areas were identified, including cellular markers using immunohistochemistry, genomics, and transcriptomic studies.

CONCLUSIONS AND CLINICAL IMPORTANCE

To date, no single diagnostic criterion or known biomarker reliably differentiates inflammatory lesions from neoplastic lymphoproliferations in the intestinal tract of cats and a diagnosis currently is established by integrating all available clinical and diagnostic data. Histopathology remains the mainstay to better differentiate LPE from LGITL in cats with chronic enteropathy.